Mutant KRAS activates several signaling pathways in the pancreas to reprogram pancreatic acini into pancreatic cancer.65 Transgenic overexpression of KRAS resulted in the development of invasive pancreatic cancer in mice. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.